Kohima News Paper

Migraine Drugs Market Industry Analysis, Demand, Growth Rate and Forecast 2020-2025

 Breaking News
  • No posts were found

Migraine Drugs Market Industry Analysis, Demand, Growth Rate and Forecast 2020-2025

October 07
17:30 2020
Migraine Drugs Market Industry Analysis, Demand, Growth Rate and Forecast 2020-2025

Migraine Drugs Market
The global migraine drugs market grew at a CAGR of around 14% during 2014-2019. Looking forward, IMARC Group expects the global migraine drugs market to exhibit strong growth during the forecast period (2020-2025).

According to the latest report by IMARC Group, titled “Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global migraine drugs market grew at a CAGR of around 14% during 2014-2019. Migraine is a neurological condition that causes severe headache accompanied with various autonomic symptoms, such as nausea, vomiting, photophobia, and phonophobia. The diagnosis of this condition is determined based on patient clinical history, reported symptoms, magnetic resonance imaging, and computerized tomography scans. Currently, over-the-counter (OTC) medicines and prescribed injections are widely available to relieve the symptoms and reduce the frequency of migraine attacks. These medicines are either administered regularly or during attacks of chronic pain.

Request Free Sample Report: https://www.imarcgroup.com/migraine-drugs-market/requestsample

The high prevalence of migraine based on the hectic consumer work schedules and sedentary lifestyles is augmenting the demand for migraine drugs. Moreover, several improvements in the reimbursement policies for migraine medications, along with the growing demand for precision drugs, are also augmenting the market growth. Furthermore, the increasing adoption of electrical nerve stimulating devices to treat migraine and faster drug approvals by several regulatory bodies are also propelling the global market. In addition to this, the introduction of calcitonin gene-related peptide (CGRP)-based therapies is expected to further drive the global market for migraine drugs. Looking forward, IMARC Group expects the global migraine drugs market to exhibit strong growth during the forecast period (2020-2025).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global migraine drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region,  treatment type, drug type, route of administration and distribution channel.

Breakup by Treatment Type:

  • Abortive Treatment
  • Preventive Treatment 

Breakup by Drug Type:

  • Triptans
  • Ergot Alkaloids
  • NSAIDs
  • Acetylcholine Inhibitors/ Neurotoxins
  • Ditans
  • CGRP mAbs
  • Others

Breakup by Route of Administration:

  • Oral
  • Injectable
  • Others

Breakup by Distribution Channel:

  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Competitive Landscape Key Player:

  • Abbott Laboratories
  • Allergan Plc (Abbvie Inc.)
  • Amgen Inc.
  • AstraZeneca Plc
  • Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
  • Eisai Co. Ltd.
  • Eli Lilly and Company
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Limited

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/migraine-drugs-market

Other Reports By IMARC Group:

Fertilizer Market: https://www.imarcgroup.com/fertilizer-market
Commercial Telematics Market: https://www.imarcgroup.com/commercial-telematics-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1 6317911145
Address:30 N Gould St, Ste R
City: Sheridan
State: WY 82801
Country: United States
Website: https://www.imarcgroup.com/

Categories